CYCLOPHOSPHAMIDE |
Synonyms. Cyclophosphamide; Ciclophosphamide; Cyclophosphamidum; Cyklofosfamid; (RS)-Cyclophosphamide; Ciclofosfamida; 1-Bis(2-chloroethyl)amino-1-oxo-2-aza- 5-oxaphosphoridin; 2-(Bis(2-chloroethyl) amino)-2H-1,3,2-oxazaphosphorine 2-oxide; 2-(Bis(2-chloroethyl) amino) tetrahydro -2H- 1,3,2-oxazophosphorine 2-oxide; Endoxanal; 4-Hydroxy- cyclophosphan- mamo phosphatide; Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester; Genoxal; N,N-Bis(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide; N,N-Bis(beta-chloroethyl)-N',O- trimethylenephosphoric acid ester diamide; Zyklophosphamid; |
|
Click for original image
|
PRODUCT IDENTIFICATION |
CAS RN |
50-18-0 (anhydrous), 6055-19-2 (monohydrate) |
EINECS RN |
200-015-4 |
FORMULA |
C7H15Cl2N2O2P |
MOLE WEIGHT |
261.09 |
H.S CODE |
2934.99.9000 |
SMILES |
N([P@@]1(NCCCO1)=O)(CCCl)CCCl |
CLASSIFICATION |
Imidazotetrazine alkylating agent, Antineoplastic agent,Defleecing agent |
EXTRA NOTES |
Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the liver to form the active aldophosphamide. It has been used in the treatment of lymphoma and leukemia. Its side effect, alopecia, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer
(Mesh). Overall Carcinogenic Evaluation: Group 1 Other RN: 60007-95-6, 75526-90-8 |
PHYSICAL AND CHEMICAL PROPERTIES |
PHYSICAL STATE. |
white
to off-white crystalline powder |
MELTING POINT |
51
~ 52 C |
BOILING POINT |
|
DENSITY
|
|
SOLUBILITY IN WATER |
40 g/l |
SOLVENT SOLUBILITY |
Sparingly soluble in ether and acetone. Soluble in alcohol, benzene, ethylene glycol, chloroform, dioxane. |
VAPOR DENSITY |
|
log P(octanol-water) |
0.63 |
VAPOR
PRESSURE |
|
AUTOIGNITION TEMP
|
|
pK |
15.29
|
REFRACTIVE INDEX |
|
FLASH
POINT |
|
STABILITY AND REACTIVITY |
STABILITY |
Stable under normal conditions. |
INCOMPATIBLE MATERIALS
|
Strong
oxidizing agents. |
POLYMERIZATION |
Has not been reported |
NFPA RATINGS |
Health: 2,
Flammability:
0, Reactivity: 0 |
EXTERNAL LINKS & GENERAL DESCRIPTION |
Wikipedia Linking - Cyclophosphamide
Google Scholar Search - Cyclophosphamide
Drug Information Portal (U.S. National Library of Medicine) - Cyclophosphamide
PubChem Compound Summary
- Cyclophosphamide
Drug
Bank - Cyclophosphamide
KEGG (Kyoto Encyclopedia of Genes and Genomes) - Cyclophosphamide
http://www.ebi.ac.uk/ - Cyclophosphamide
http://www.ncbi.nlm.nih.gov/ - Cyclophosphamide
http://toxnet.nlm.nih.gov/ Hazardous Substances Data Bank - Cyclophosphamide
http://www.vcu.edu/ Cyclophosphamide (Cytoxan®, CPH, CAS No. 50-18-0) is an antineoplastic compound that is chemically related to nitrogen mustard. Cyclophosphamide is an odorless, fine white to off-white crystalline powder that is soluble in water and ethanol (NTP, 2005). Cyclophosphamide is used clinically to treat a wide range of cancers including malignant lymphomas, myeloma, leukemia, mycosis fungoides, neuroblastoma, adenocarcinoma, retinoblastoma, and breast carcinoma (Bristol-Myers Squibb Co, 2003). Other clinical uses for CPH include immunosuppressive therapy following organ transplants or as a treatment for autoimmune disorders such as rheumatoid arthritis, Wegener’s granulomatosis, and nephritic syndrome in children (Chabner et al., 2001). Metabolism of CPH takes place in the liver and undergoes metabolic activation by cytochrome P450 isoenzyme 2B (Chabner et al., 2006). The major circulating metabolite of CPH, 4-Hydroxycyclophosphamide, is in equilibrium with its tautomer, aldophosphamide, which is spontaneously broken down to produce phosphoramide mustard and acrolein (Zhang et al., 2005). Phosphoramide mustard is responsible for anti-tumor effects, while acrolein is responsible for the hemorrhagic cystitis observed during CPH therapy (Chabner et al., 2006).....
|
SALES SPECIFICATION |
APPEARANCE |
white
to off-white crystalline powder |
ASSAY
|
98.5%
min
|
MELTING POINT |
51
~ 52 C
|
IMPURITY |
1.0%
max (total), 0.5% max (individual) |
LOSS
ON DRYING |
1.0%
max
|
HEAVY METALS |
20ppm
max
|
RESIDUE ON IGNITION |
0.1%
max
|
TRANSPORT & REGULATORY INFORMATION |
UN
NO. |
3464 |
HAZARD CLASS
|
6.1 |
PACKING GROUP |
III |
SAFETY
INFORMATION
|
HAZARD OVERVIEW |
May cause respiratory irritation. May cause genetic defects. Toxic if swallowed. Causes serious eye irritation. May cause cancer. Causes skin irritation. May damage the unborn child |
GHS
|
|
SIGNAL WORD |
Danger |
PICTOGRAMS |
|
HAZARD STATEMENTS |
H335-H340-H301-H319-H350-H315-H360D |
P STATEMENTS |
P301 + P310-P201-P308 + P313-P261-P302+ P352-P280-P305 + P351 + P338 |
EC DIRECTIVES |
|
HAZARD
CODES |
T |
RISK PHRASES |
45-46-61-25-36/37/38 |
SAFETY PHRASES
|
53-26-37/39-45 |
PACKING |
Preserve in light-resistant and
well-closed containers | |